US 10968249
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 10968249 (Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P13/12, A61P3/00